Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients
暂无分享,去创建一个
J. Nurnberger | E. Gershon | Gregory M. Brown | P. Gold | D. Jimerson | M. Ebert | J. Guroff | E. Dibble | L. R. Kessler | F. Storch | S. Simmons | Suzanne S. Jimerson | P. Gold
[1] G. Asnis,et al. Paradoxical cortisol responses to dextroamphetamine in endogenous depression. , 1981, Archives of general psychiatry.
[2] R. Post,et al. Heterogeneity of amphetamine response in depressed patients. , 1981, The American journal of psychiatry.
[3] S. Markey,et al. Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. , 1981, Biomedical mass spectrometry.
[4] G. Asnis,et al. The prolactin response to intravenous dextroamphetamine in normal young men and postmenopausal women. , 1981, Life sciences.
[5] J. Nurnberger,et al. Dextroamphetamine and arecoline as pharmacogenetic probes in normals and remitted bipolar patients , 1981 .
[6] J. Nurnberger,et al. Sex, plasma prolactin and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) predict heritable d-amphetamine excitation in man , 1981 .
[7] I. Kopin,et al. Catecholamine metabolism in primary anorexia nervosa. , 1979, The Journal of clinical endocrinology and metabolism.
[8] B. Carr,et al. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. , 1979, The Journal of clinical endocrinology and metabolism.
[9] M. Ebert,et al. Comparison of radioimmunoassay and gas chromatographic mass spectrometric assay for d-amphetamine. , 1979, Biomedical mass spectrometry.
[10] C. Mazure,et al. Blindness and reliability in lifetime psychiatric diagnosis. , 1979, Archives of general psychiatry.
[11] W. Bunney,et al. HETEROGENEITY IN RESPONSE TO AMPHETAMINE IN SCHIZOPHRENIA: EFFECTS OF PLACEBO, CHRONIC PIMOZIDE AND PIMOZIDE WITHDRAWAL , 1979 .
[12] W. Bunney,et al. d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment. , 1978, Life sciences.
[13] R. S. Sloviter,et al. Evidence that serotonin mediates some behavioral effects of amphetamine. , 1978, The Journal of pharmacology and experimental therapeutics.
[14] E. Gershon,et al. Genetic strategies in biological psychiatry. , 1978, Archives of general psychiatry.
[15] M S Buchsbaum,et al. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. , 1978, Science.
[16] R. Takahashi,et al. Hypersensitive Serotonergic Receptors Involved in Clinical Depression—A Theory , 1978 .
[17] E. Vesell,et al. Twin studies in pharmacogenetics. , 1978, Human genetics. Supplement.
[18] W. Ganong. NEUROTRANSMITTERS INVOLVED IN ACTH SECRETION: CATECHOLAMINES * † , 1977, Annals of the New York Academy of Sciences.
[19] D. Krieger. SEROTONIN REGULATION OF ACTH SECRETION , 1977, Annals of the New York Academy of Sciences.
[20] K. Kellar,et al. SEROTONIN INVOLVEMENT IN PITUITARY‐ADRENAL FUNCTION , 1977, Annals of the New York Academy of Sciences.
[21] Mortyn T. Jones,et al. NEUROTRANSMITTER REGULATION OF CORTICOTROPIN‐RELEASING FACTOR IN VITRO , 1977, Annals of the New York Academy of Sciences.
[22] I. Lancranjan,et al. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man. , 1977, The Journal of clinical endocrinology and metabolism.
[23] J. Clemens,et al. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. , 1977, Endocrinology.
[24] R. Post,et al. A neuronal receptor sensitivity mechanism in affective illness (a review of evidence). , 1977, Communications in psychopharmacology.
[25] W. Bunney,et al. Genetic studies and biologic strategies in the affective disorders. , 1977, Progress in medical genetics.
[26] G. Nisticó,et al. Neurotransmitters and Anterior Pituitary Function , 1977 .
[27] G. Langer,et al. Reduced growth hormone responses to amphetamine in "endogenous" depressive patients: studies in normal, "reactive" and "endogenous" depressive, schizophrenic, and chronic alcoholic subjects. , 1976, Archives of general psychiatry.
[28] J. Sassin,et al. Cortisol and GH responses to D- and L-amphetamine in monkeys. , 1976, Endocrinology.
[29] K. Chihara,et al. Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep. , 1976, The Journal of clinical investigation.
[30] J. Chambers,et al. Neurotransmitter regulation of growth hormone and ACTH in the rhesus monkey: effects of biogenic amines. , 1976, Endocrinology.
[31] P. Groves,et al. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. , 1976, Annual review of psychology.
[32] S. Lal,et al. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. , 1975, The Journal of clinical endocrinology and metabolism.
[33] D. Krieger,et al. Cyproheptadine-induced remission of Cushing's disease. , 1975, The New England journal of medicine.
[34] G. Smythe,et al. Serotoninergic control of rat growth hormone secretion. , 1975, Neuroendocrinology.
[35] J. Tecce,et al. Amphetamine Effects in Man: Paradoxical Drowsiness and Lowered Electrical Brain Activity (CNV) , 1974, Science.
[36] G. Smythe,et al. Suppression of human growth hormone secretion by melatonin and cyproheptadine. , 1974, The Journal of clinical investigation.
[37] S. Ross,et al. Drugs and Placebos: Drug Guessing by Normal Volunteers , 1973, Psychological reports.
[38] D. Janowsky,et al. A cholinergic-adrenergic hypothesis of mania and depression. , 1972, Lancet.
[39] J. Axelrod,et al. EFFECTS OF URINARY pH ON AMPHETAMINE METABOLISM , 1971, Annals of the New York Academy of Sciences.
[40] G. Besser,et al. Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine , 1970, Nature.
[41] G. Oxenkrug,et al. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. , 1969, Lancet.
[42] J. Schildkraut,et al. The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.
[43] D. Schalch,et al. A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma , 1964, Nature.